Josep Samitier
Group leader
Vitala is born, a spin-off of IBEC that offers innovative and more ethical solutions for health research
Vitala Technologies, a biotechnology-based company born in the Institute for Bioengineering of Catalonia (IBEC), will offer innovative solutions for the analysis of drugs during their development, as well as the possibility to know in advance and in a personalized way, what will be the response of a patient to a certain treatment.
The scientific-technological alliance of IBEC and Leitat in the media
The Institute for Bioengineering of Catalonia (IBEC) appears in the “Diari de Terrassa” for its alliance with the LEITAT Technological Center to promote the development and application of cutting-edge technologies that will combine engineering and biology to find solutions to health problems.
LEITAT and IBEC will promote last generation biotechnologies from Barcelona
A recent alliance between the LEITAT Technological Center and the Institute for Bioengineering of Catalonia (IBEC) will give a new impulse in the development and application of cutting-edge technologies that will combine engineering and biology to find solutions to health problems. Both institutions have established a new agreement to promote innovation in different scientific and technological areas, including 3D bioprinting with bioinks.
Advance in research against childhood cancer in the #WorldResearchCancerDay
IBEC researchers appear in different media for the recent study senior-authored by Joan Montero and first-authored by Albert Manzano, Senior Researcher and PhD student in IBEC’s Nanobioengineering group in which they have used a state-of-the-art analysis technique to evaluate new drug combinations to successfully treat acute lymphoblastic leukemia.
Personalised medicine to beat pediatric leukemia
IBEC researchers have used a state-of-the-art analysis technique to evaluate new drug combinations to successfully treat acute lymphoblastic leukemia. This study brings personalised medicine closer to the clinic for this cancer type.
A chip against chronic bacterial infections
IBEC researchers develop a device that allows to grow biofilms and analyze their susceptibility to different antibiotics in a simple way and using patient samples. BiofilmChip, a low-cost, easy-to-use diagnostic device, opens the way to finding effective and custom treatments against chronic infections produced by biofilms.
The third medical revolution: regenerative medicine
Josep Samitier, director of IBEC, appears in an article published in the journal “Muy Interesante” that deals with the revolution of regenerative medicine and its possible medical applications.
Josep Samitier and the “Science Law” in the media